Home/Pipeline
Program
PreclinicalPhase 1Phase 2Phase 3FiledApproved
Next milestoneCLV-158Pancreatic cancer (KRAS)Oncology · Small molecule
IND filing 2027
CLV-325ALSNeuroscience · RNA
Candidate selected
CLV-522Rett syndromeRare Disease · Gene therapy
IND-enabling studies
Pipeline as of September 30, 2026. Programs and data are fictional.